Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net Income (loss)	$ (2,034,435)	$ (17,753,838)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss from discontinued operations	335,993	11,447,910
Depreciation and amortization	217,236	219,986
Stock-based compensation	710,550	1,276,455
Deferred income tax expense	(42,934)	(3,019,124)
Amortization of right-of-use assets	130,535	183,070
Accretion of deferred acquisition consideration	27,370	80,098
Gain on litigation settlement	(1,442,468)	0
Gain on sale of equity investment and settlement of contingent consideration receivable	(382,525)	0
Equity in loss of affiliate	245,525	0
Changes in operating assets and liabilities:
Accounts receivable	511,697	35,303
Prepaid expenses and other current assets	158,242	(15,455)
Other assets	60,886	(2,205)
Accounts payable	(170,348)	(76,710)
Contract liabilities	(68,216)	(4,079)
Accrued payroll and related liabilities and other accrued liabilities	(76,574)	235,259
Operating lease liability	(207,186)	(192,128)
Commissions payable	(94,810)	(99,217)
Cash used in operating activities of continuing operations	(2,121,462)	(7,684,675)
Cash used in operating activities of discontinued operations	(693,106)	1,670,714
Net cash used in operating activities	(2,814,568)	(6,013,961)
Cash flows from investing activities
Acquisition of property and equipment	0	(535,902)
Proceeds from sale of equity investment and settlement of contingent consideration receivable	1,400,000	0
Proceeds from disposal of business	935,974	0
Net cash provided by (used in) investing activities	2,335,974	(535,902)
Cash flows from financing activities
Borrowings under revolving line of credit	575,000	425,000
Repayments under revolving line of credit	(500,000)	0
Premium financing borrowings	305,759	0
Premium financing repayments	(305,759)	0
Proceeds from issuance of stock	347,108	1,887,000
Proceeds from exercise of stock options	7,400	37,642
Net cash provided by financing activities	429,508	2,349,642
Net decrease in cash and cash equivalents	(49,086)	(4,200,221)
Cash and cash equivalents, beginning of period	731,081	4,931,302
Cash and cash equivalents, end of period	681,995	731,081
Supplemental cash flow Information
Interest paid	73,678	1,250
Non-cash investing and financing activities:
Non-cash proceeds on disposal of business	1,263,000	0
Value of common stock issued in connection with common stock purchase agreement	$ 0	$ 150,000